Weight Loss And Obesity Management Market, by Product and Services (Drugs, Supplements, Equipment, Services), by Age Group (Children, Adults, Geriatric), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Jul 2023

Code : CMI3448

Pages :170

Formats :

Excel and PDF

Industry : Medical Devices

Weight Loss And Obesity Management MarketSize and Trends

The global weight loss and obesity management market is estimated to be valued at US$ 225.66 billion in 2023 and is expected to exhibit a CAGR of 7.9% during the forecast period (2023-2030).

Figure 1. Global Weight Loss And Obesity Management Market Share (%), by Product & Services, 2023

Global Weight Loss And Obesity Management Market– Driver

Increasing prevalence of obesity

Global Weight Loss And Obesity Management Market: Key Trends

Increasing approval of weight management therapies is expected to drive the weight loss and obesity management market growth over the forecast period.

Increasing approval of weight management therapies is expected to drive the weight loss and obesity management market growth over the forecast period. For instance, June 2021, Novo Nordisk A/S, a multinational pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has approved Wegovy (the brand name for once-weekly semaglutide 2.4 mg injection in the U.S.) for chronic weight management.